首页> 外文期刊>European review for medical and pharmacological sciences. >LncRNA RPPH1 predicts poor prognosis and regulates cell proliferation and migration by repressing P21 expression in gastric cancer
【24h】

LncRNA RPPH1 predicts poor prognosis and regulates cell proliferation and migration by repressing P21 expression in gastric cancer

机译:LNCRNA RPPH1预测预后差,通过抑制胃癌中的P21表达来调节细胞增殖和迁移

获取原文
           

摘要

OBJECTIVE: The purpose of this study was to explore the expression and biological functions of long non-coding ribonucleic acid (lncRNA) ribonuclease P RNA component H1 (RPPH1) in gastric cancer (GC), and to analyze the correlations of lncRNA expression with the clinical features and prognosis of GC patients. PATIENTS AND METHODS: The relative expression of RPPH1 in tissue specimens from 60 GC patients was measured via quantitative Reverse Transcription-Polymerase Chain Reaction (qRT-PCR), and the correlations of RPPH1 expression with tumor-node-metastasis (TNM) stage, lymph node metastasis, etc. in GC patients were analyzed. Then, qRT-PCR was performed to detect the relative expression level of RPPH1 in GC cells. Moreover, colony formation assay, 5-Ethynyl-2′-deoxyuridine (EdU) staining, wound-healing assay, and transwell assay were employed to investigate the influence of RPPH1 on GC cell functions. After interfering in the expression of RPPH1, the changes in p21 (CDKN1A, cyclin dependent kinase inhibitor 1A) expression were determined through qRT-PCR and Western blotting. RESULTS: It was shown in qRT-PCR assay results that the expression of RPPH1 was upregulated in 60 cases of GC tissues. Statistical analysis revealed that RPPH1 expression was positively correlated with the TNM stage, lymph node metastasis, and infiltration depth in GC patients. Besides, highly expressed lncRNA RPPH1 suggested poor prognosis of GC patients. Based on the results of qRT-PCR assay, the expression of RPPH1 in GC cells was upregulated. After interfering in RPPH1 expression, both colony formation assay and EdU staining indicated that the proliferative capacity of GC cells was repressed. Furthermore, it was manifested in the results of wound-healing and transwell assays that the migratory and invasive abilities of GC cells were weakened. Finally, the qRT-PCR and Western blotting assay results demonstrated that p21 expression was upregulated after interfering in the expression of RPPH1 in GC cells. CONCLUSIONS: The expression of lncRNA RPPH1 is upregulated in GC, suggesting that the prognosis of the patients is poor. Highly expressed RPPH1 promotes the proliferation and metastasis of GC cells by regulating p21 expression.
机译:目的:本研究的目的是探讨胃癌(GC)中长的非编码核糖核酸(LNCRNA)核糖核酸酶P RNA组分H1(RPPH1)的表达和生物学功能,并分析LNCRNA表达的相关性GC患者的临床特征及预后。患者和方法:通过定量逆转录 - 聚合酶链反应(QRT-PCR)测量来自60gC患者组织标本的RPPH1中的相对表达,以及RPPH1表达与肿瘤 - 节点转移(TNM)阶段,淋巴结的相关性分析了GC患者中的节点转移等。然后,进行QRT-PCR以检测GC细胞中RPP1的相对表达水平。此外,使用菌落形成测定,5-乙炔基-2'-脱氧核(EDU)染色,伤口愈合测定和Transwell测定来研究RPPH1对GC细胞功能的影响。干扰RPPH1的表达后,通过QRT-PCR和Western印迹测定P21(CDKN1A,Cyclin依赖性激酶抑制剂1A)表达的变化。结果:在QRT-PCR测定中显示,RPPH1的表达在60例GC组织中上调。统计分析显示,RPPH1表达与GC患者中的TNM阶段,淋巴结转移和浸润深度呈正相关。此外,高表达的LNCRNA RPP1表明GC患者的预后不良。基于QRT-PCR测定的结果,上调了GC细胞中RPPH1的表达。干扰RPPH1表达后,菌落形成测定和EDU染色表明,抑制了GC细胞的增殖能力。此外,它表现为伤口愈合的结果和转发测定,即GC细胞的迁移和侵袭能力被削弱。最后,QRT-PCR和Western印迹测定结果表明,在干扰GC细胞中干扰RPPH1的表达后,上调P21表达。结论:在GC上上调LNCRNA RPP1的表达,表明患者的预后差。高表达的RPPH1通过调节P21表达来促进GC细胞的增殖和转移。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号